From the Editor-in-Chief: Stem-to-Stern, Continuous Process for Biologics?
BioProcessing Journal · 27.07.2026 · 4
DOI: 10.12665/j123.carson ↗Kurz gefasst
Fachartikel in der Zeitschrift BioProcessing Journal, online erschienen am 27.07.2026. Verfasst von Keith L. Carson.
Abstract (Originalsprache)
Call me jaded. One of the latest fads in the production of biologics is “continuous processing.” So let’s concede that the upstream realm can lend itself to continuous processing, but the really hard stuff was always on the downstream side. Here we’ve had to deal with product clarification and purification, which typically involve crossflow (tangential) filtration and chromatography run in a batch mode, with regeneration steps in between whatever was considered a batch...
Zitieren
APA
Carson, K. L. (2026). From the Editor-in-Chief: Stem-to-Stern, Continuous Process for Biologics?. BioProcessing Journal, 4. https://doi.org/10.12665/j123.carson
Vancouver
Carson KL. From the Editor-in-Chief: Stem-to-Stern, Continuous Process for Biologics?. BioProcessing Journal. 2026:4. doi:10.12665/j123.carson
BibTeX
@article{Carson2026,
author = {Carson, Keith L.},
title = {From the Editor-in-Chief: Stem-to-Stern, Continuous Process for Biologics?},
journal = {BioProcessing Journal},
year = {2026},
pages = {4},
doi = {10.12665/j123.carson}
}
EUVIMED